サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541316

在宅輸液療法市場レポート：製品・用途・地域別、2024～2032年

Home Infusion Therapy Market Report by Product, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 150 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
在宅輸液療法市場レポート：製品・用途・地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の在宅輸液療法市場規模は2023年に432億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに691億米ドルに達し、2024～2032年の間に5.2％の成長率（CAGR）を示すと予測しています。慢性疾患の有病率の上昇、在宅医療への嗜好の高まり、継続的な製品革新が市場を牽引する主要要因のひとつです。

在宅輸液療法は、抗ウイルス薬や免疫グロビンなどの薬剤、輸液、栄養剤を、ポンプ、カテーテル、バイアルなどのさまざまな機器を通して、自宅にいながら患者に静脈内投与する専門的な治療法です。感染症、がん、多発性硬化症（MS）や関節リウマチなどの慢性疾患で、長期または頻回の点滴療法が必要な患者に推奨されます。在宅輸液療法は快適さと利便性を提供し、生活の質を向上させ、院内感染のリスクを軽減します。さらに、必要な医療を受けながら、患者さんが自立心を保ち、治療をコントロールできるようになります。在宅輸液療法は、化学療法や水分補給、経腸、強心、抗感染、栄養、疼痛管理など、主に糖尿病やさまざまな消化器疾患、腫瘍疾患の治療に非常に有効です。

在宅輸液療法市場動向

がん、変形性関節症、ヒト免疫不全ウイルス（HIV）、糖尿病などの慢性疾患を患う人々の増加は、市場成長を促進する主要因のひとつです。これと同時に、生命を脅かす疾病に罹患しやすく、輸液療法などの定期的な治療が必要な高齢者人口の増加が、市場成長にプラスの影響を与えています。さらに、多くの政府イニシアティブや有利な償還政策の実施、長期入院にかかる費用の高騰が、患者に在宅輸液療法を選択するよう促しており、これが市場の成長に寄与しています。このほか、利便性と費用対効果の高さから在宅医療サービスへの嗜好が変化していることや、病院のスペースやベッドに対するニーズが高まっていることも、市場の成長を強めています。これに伴い、汚染された器具、ベッドリネン、空気飛沫に長時間さらされることによる院内感染（HAI）の流行が増加していることも、市場拡大の一助となっています。これに加えて、専門的な投与を必要とする特殊薬剤の需要が広がっていることも、もう一つの重要な成長促進要因として作用しています。さらに、点滴治療を正確かつリアルタイムにモニタリングするための高度な点滴システムを備えた、軽量で持ち運びが可能で使いやすい輸液ポンプの開拓など、革新的な技術の進歩が市場に有益な成長機会をもたらしています。

本レポートで扱う主要質問

  • 世界の在宅輸液療法市場はこれまでどのように推移してきたか？
  • 世界の在宅輸液療法市場における促進要因、抑制要因、機会は何か？
  • 各駆動要因、抑制要因、機会が世界の在宅輸液療法市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的な在宅輸液療法市場はどの国か？
  • 製品別の市場内訳は？
  • 在宅輸液療法市場で最も魅力的な製品はどれですか？
  • 用途別の市場内訳は？
  • 在宅輸液療法市場で最も魅力的な用途は？
  • 世界の在宅輸液療法市場の競合構造は？
  • 世界の在宅輸液療法市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の在宅輸液療法市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 輸液ポンプ
    • 市場動向
    • 主要セグメント
      • エラストマー
      • 電気機械
      • 重力
      • その他
    • 市場予測
  • 点滴セット
  • IVカニューレ
  • ニードルレスコネクタ

第7章 市場内訳：用途別

  • 抗感染
  • 内分泌学
    • 市場動向
    • 主要セグメント
      • 糖尿病
      • その他
    • 市場予測
  • 水分補給療法
    • 市場動向
    • 主要セグメント
      • アスリート
      • その他
    • 市場予測
  • 化学療法
  • 経腸栄養
  • 経腸栄養
  • 専門医薬品
  • その他

第8章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第9章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • JMS Co. Ltd.
    • Nipro Corporation
    • Option Care Health Inc.（Walgreen Co.）
    • Smiths Group plc
    • Terumo Corporation
図表

List of Figures

  • Figure 1: Global: Home Infusion Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Home Infusion Therapy Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Home Infusion Therapy Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Home Infusion Therapy Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Home Infusion Therapy Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Home Infusion Therapy Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Home Infusion Therapy (Infusion Pumps) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Home Infusion Therapy (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Home Infusion Therapy (Intravenous Sets) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Home Infusion Therapy (Intravenous Sets) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Home Infusion Therapy (IV Cannulas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Home Infusion Therapy (IV Cannulas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Home Infusion Therapy (Needleless Connectors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Home Infusion Therapy (Needleless Connectors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Home Infusion Therapy (Anti-Infective) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Home Infusion Therapy (Anti-Infective) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Home Infusion Therapy (Endocrinology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Home Infusion Therapy (Endocrinology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Home Infusion Therapy (Hydration Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Home Infusion Therapy (Hydration Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Home Infusion Therapy (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Home Infusion Therapy (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Home Infusion Therapy (Enteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Home Infusion Therapy (Enteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Home Infusion Therapy (Parenteral Nutrition) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Home Infusion Therapy (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Home Infusion Therapy (Specialty Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Home Infusion Therapy (Specialty Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Home Infusion Therapy (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Home Infusion Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Home Infusion Therapy Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Home Infusion Therapy Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Home Infusion Therapy Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Home Infusion Therapy Industry: SWOT Analysis
  • Figure 81: Global: Home Infusion Therapy Industry: Value Chain Analysis
  • Figure 82: Global: Home Infusion Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Home Infusion Therapy Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Home Infusion Therapy Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Home Infusion Therapy Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Home Infusion Therapy Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Home Infusion Therapy Market: Competitive Structure
  • Table 6: Global: Home Infusion Therapy Market: Key Players
目次
Product Code: SR112024A4098

The global home infusion therapy market size reached US$ 43.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. The rising prevalence of chronic diseases, the increasing preference for home healthcare, and ongoing product innovations represent some of the key factors driving the market.

Home infusion therapy is a specialized medical treatment involving the administration of medication, such as antivirals or immune globin, fluids, or nutrition intravenously through various equipment, including pumps, catheters, and vials, to patients in the comfort of their homes. It is recommended for patients with infections, cancer, or chronic conditions like multiple sclerosis (MS) or rheumatoid arthritis requiring long-term or frequent infusion therapy. Home infusion therapy offers comfort and convenience, improves the quality of life, and reduces the risk of hospital-acquired infections. In addition to this, it allows patients to maintain a sense of independence and control over their treatment while still receiving the necessary medical care. Home infusion therapy is highly effective in chemotherapy and hydration, enteral, inotropic, anti-infective, nutritional, and pain management therapies that are primarily used for treating diabetes and various gastrointestinal and oncological disorders.

Home Infusion Therapy Market Trends:

The rise in the number of people suffering from chronic diseases, such as cancer, osteoarthritis, human immunodeficiency viruses (HIV), and diabetes, represents one of the prime factors driving the market growth. Concurrent with this, the increase in the geriatric population prone to life-threatening diseases and requiring regular medical attention, such as infusion therapy, is positively impacting the market growth. Moreover, the implementation of numerous government initiatives and favorable reimbursement policies and the surging costs of extended hospital stays are prompting patients to opt for home infusion therapy, which, in turn, is contributing to the market growth. Besides this, the shifting preference for home healthcare services due to their convenience and cost-effectiveness and the growing need for space and beds in hospitals are strengthening the market growth. In line with this, the rising prevalence of hospital-acquired infections (HAIs) due to elongated exposure to contaminated equipment, bed linens, and air droplets is aiding in market expansion. In addition to this, the widespread demand for specialty drugs which require specialized administration is acting as another significant growth-inducing factor. Furthermore, innovative technological advancements, such as the development of lightweight, portable, and easy-to-use infusion pumps equipped with advanced drip systems for precise and real-time monitoring of IV treatments, are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global home infusion therapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and application.

Product Insights:

Infusion Pumps

Elastomeric

Electromechanical

Gravity

Others

Intravenous Sets

IV Cannulas

Needleless Connectors

The report has provided a detailed breakup and analysis of the home infusion therapy market based on the product. This includes infusion pumps (elastomeric, electromechanical, gravity, and others), intravenous sets, IV cannulas, and needleless connectors. According to the report, infusion pumps represented the largest segment.

Application Insights:

Anti-Infective

Endocrinology

Diabetes

Others

Hydration Therapy

Athletes

Others

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Others

A detailed breakup and analysis of the home infusion therapy market based on the application has also been provided in the report. This includes anti-infective, endocrinology (diabetes and others), hydration therapy (athletes and others), chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. According to the report, anti-infectives accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for home infusion therapy. Some of the factors driving the North America home infusion therapy market included the expanding prevalence of cancer, HIV, and diabetes, the widespread adoption of home healthcare, and numerous technological advancements in the industry.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global home infusion therapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc, and Terumo Corporation. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global home infusion therapy market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global home infusion therapy market?
  • What is the impact of each driver, restraint, and opportunity on the global home infusion therapy market?
  • What are the key regional markets?
  • Which countries represent the most attractive home infusion therapy market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the home infusion therapy market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the home infusion therapy market?
  • What is the competitive structure of the global home infusion therapy market?
  • Who are the key players/companies in the global home infusion therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Home Infusion Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Infusion Pumps
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Elastomeric
      • 6.1.2.2 Electromechanical
      • 6.1.2.3 Gravity
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Intravenous Sets
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 IV Cannulas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Needleless Connectors
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Anti-Infective
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endocrinology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Diabetes
      • 7.2.2.2 Others
    • 7.2.3 Market Forecast
  • 7.3 Hydration Therapy
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Athletes
      • 7.3.2.2 Others
    • 7.3.3 Market Forecast
  • 7.4 Chemotherapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Enteral Nutrition
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Parenteral Nutrition
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Specialty Pharmaceuticals
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 B. Braun Melsungen AG
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Baxter International Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Becton Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Eli Lilly and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Fresenius SE & Co. KGaA
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 ICU Medical Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 JMS Co. Ltd.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Nipro Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Option Care Health Inc. (Walgreen Co.)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Smiths Group plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Terumo Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis